SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-02-003707
Filing Date
2002-08-13
Accepted
2002-08-13 16:30:33
Documents
3
Period of Report
2002-06-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b43659ane10vq.htm 10-Q 171146
3 EX-10.1 SUBLEASE AGREEMENT b43659anexv10w1.txt EX-10.1 176620
5 ANTIGENICS INC. 10-Q COURTESY COPY b43659ane10vqxpdfy.pdf 10-Q 268105
  Complete submission text file 0000950135-02-003707.txt   617649
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 02730094
SIC: 2836 Biological Products, (No Diagnostic Substances)